The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Aggreko runs out of power after Peel Hunt downgrade

Tue, 22nd Jan 2019 13:35

(Sharecast News) - Aggreko ran out of power on Tuesday after Peel Hunt downgraded its stance on the stock to 'reduce' from 'hold' and cut the price target to 700p from 800p as it argued that challenges remain "significant".The broker said management at the temporary power provider is performing well across "tricky" markets, with the third-quarter update providing some reassurance that Aggreko remains on course, but the "ever-shifting challenges" remain significant.Peel Hunt said challenges are significant given the utility business appears to be in structural decline, the cycle exposures, working capital pressures and the growing competition from 'generalists' who continue to invest and expand."We are wary that the fragile global macro-economic backdrop is likely to lead to customer hesitancy and greater off-hire risk," said analyst Andrew Nussey."Although self-help will mitigate some earnings pressure and support an improving return on capital employed profile, the pace of ROCE recovery looks to be under increasing external pressure."At 1450 GMT, the shares were down 4.1% at 718p.

Related Shares

More News
9 Dec 2022 10:27

Aggreko to buy Crestchic in £122m deal

(Sharecast News) - Temporary power supplier Aggreko said on Friday that it has agreed to buy specialist equipment provider Crestchic in a £122m d...

6 Aug 2021 18:20

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

2 Aug 2021 10:07

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

8 Jul 2021 21:32

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.